Allspring Global Investments Holdings, LLC Reata Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023
SELL
$79.22 - $105.37 $42,145 - $56,056
-532 Reduced 42.46%
721 $73,000
Q1 2023

Apr 13, 2023
BUY
$30.85 - $93.17 $38,655 - $116,742
1,253 New
1,253 $113,000
Q2 2022

Jul 25, 2022
SELL
$20.71 - $36.5 $68,612 - $120,924
-3,313 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$24.12 - $39.6 $9,165 - $15,048
-380 Reduced 10.29%
3,313 $108,000
Q4 2021

Jan 28, 2022
BUY
$25.61 - $110.96 $94,577 - $409,775
3,693 New
3,693 $97,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email